Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Precision Biosciences (DTIL) Return on Equity (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Return on Equity for 8 consecutive years, with 3.39% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity fell 339.0% to 3.39% in Q3 2025 year-over-year; TTM through Sep 2025 was 3.39%, a 339.0% decrease, with the full-year FY2023 number at 0.47%, up 4.0% from a year prior.
  • Return on Equity was 3.39% for Q3 2025 at Precision Biosciences, down from 2.06% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.42% in Q2 2024 to a low of 3.39% in Q3 2025.
  • A 5-year average of 0.77% and a median of 0.59% in 2023 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: soared 161bps in 2021, then crashed -339bps in 2025.
  • Precision Biosciences' Return on Equity stood at 0.41% in 2021, then crashed by -56bps to 0.64% in 2022, then fell by -23bps to 0.78% in 2023, then surged by 55bps to 0.35% in 2024, then plummeted by -871bps to 3.39% in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Return on Equity are 3.39% (Q3 2025), 2.06% (Q2 2025), and 0.74% (Q1 2025).